Jakob Dynnes Hansen

Director of Finance/CFO at ASARINA PHARMA AB

71 year

Health Technology

Consumer Services

Finance

Profile

Mr. Jakob Dynnes Hansen is an Independent Director at Nanexa AB, a Chief Financial Officer at Asarina Pharma AB and a Chief Financial Officer at Zerion Pharma A/S.
He is on the Board of Directors at Nanexa AB. Mr. Hansen was previously employed as a Chief Financial Officer by Evolva Holding SA, a Chief Financial Officer by Evolva SA, a Chief Financial Officer & Director by Allylix, Inc., a Secretary by Galecto, Inc., a Head-Market Research by Novo Nordisk A/S, a Chief Financial Officer by Nuevolution AB, a Senior Vice President-Corporate Finance by Unibank (Denmark), and a Chief Financial Officer by Zealand Pharma A/S.
He received his graduate degree from the University of Copenhagen and an MBA from INSEAD.

Jakob Dynnes Hansen active positions

Companies	Position	Start
ASARINA PHARMA AB	Director of Finance/CFO	2017-03-31
NANEXA AB	Director/Board Member	2022-12-31
Zerion Pharma A/S	Director of Finance/CFO	-

All active positions of Jakob Dynnes Hansen

Former positions of Jakob Dynnes Hansen

Companies	Position	End
DAMORA THERAPEUTICS, INC.	Corporate Secretary	2020-03-31
EVONEXT HOLDINGS SA	Director of Finance/CFO	2016-12-30
Allylix, Inc. Allylix, Inc. Pharmaceuticals: OtherHealth Technology Develops terpene products and their derivatives	Director of Finance/CFO	-
Unibank (Denmark) Unibank (Denmark) Major BanksFinance Operates as a nationally chartered commercial bank	Director of Finance/CFO	-
Evolva SA Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature	Director of Finance/CFO	-

See the detail of Jakob Dynnes Hansen's experience

Education of Jakob Dynnes Hansen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jakob Dynnes Hansen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Allylix, Inc. Allylix, Inc. Pharmaceuticals: OtherHealth Technology Develops terpene products and their derivatives	Health Technology
INSEAD INSEAD Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Zealand Pharma A/S Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines	Health Technology
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Unibank (Denmark) Unibank (Denmark) Major BanksFinance Operates as a nationally chartered commercial bank	Finance
Nuevolution AB Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases	Health Technology
Evolva SA Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature	Commercial Services
Evolva Holding SA Evolva Holding SA Food: Specialty/CandyConsumer Non-Durables Develops and sells flavors, fragrances and health ingredients	Consumer Non-Durables
Asarina Pharma AB Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Nanexa AB Nanexa AB Medical SpecialtiesHealth Technology Operates as a research intensive technology company	Health Technology
Galecto, Inc. Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases	Health Technology
Zerion Pharma A/S